The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Location contact
Radha Korupolu, MD
CONTACT
Shrasti Lohiya
CONTACT
NCT Number: NCT06891989
The purpose of this study is to evaluate the efficacy of a 6-week app-guided MM intervention compared to a 6-week app-guided health education AC condition on pain intensity, pain interference, depression, and anxiety.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Radha Korupolu, MD
CONTACT
Shrasti Lohiya
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be asked to download the Mindfulness Coach app that provides simple instructions and brief meditation exercises.This is a a gradual training program of 14 levels which will be completed in the first 2-3 weeks. Each level provides short readings about mindfulness and one or two guided meditations (a silent "seated practice" for increasing lengths of time plus typically an additional 8-13-minute meditation). As participants progress through the levels, they earn "badges" displayed in the app, and an image of a tree on the home screen grows as each successive level is completed.For the remaining weeks of the intervention, participants will select at least one (and ideally two) guided meditation per day from the complete list of available meditations.Participants will track their progress through weekly logs.
Participants will be asked to download and use the free TED Talk app, which will have 50 TED talk videos related to health that range from 3-20 minutes. Participants will be asked to watch or listen to these videos for ≥ 10 minutes daily for 6 days per week and complete weekly logs of the TED Talk app use.
Time frame: baseline , post-intervention (6 weeks after baseline)
Pain will be measured on Numeric Rating Scale (NRS) from 0(no pain) to 10(pain as bad as you can imagine)
Time frame: baseline , post-intervention (6 weeks after baseline)
This is a 10 item questionnaire, each item is typically scored on a 5-point Likert scale from 1 (Not at all) to 5 (Very much), for a maximum raw score of 50, higher scores reflect greater pain interference.
Time frame: baseline , post-intervention (6 weeks after baseline)
This is a 8 item questionnaire , each measured on a 4 point scale from 0(not at all) to 3(nearly every day), for a score range of 0-27, higher score indicating worse outcome
Time frame: baseline , post-intervention (6 weeks after baseline)
This is an 7 item questionnaire, each is scored from 0(not at all) to 3(nearly every day), for a maximum score of 21, a higher score indicating more anxiety
Contact information is provided by the study sponsor or research team.
Radha Korupolu, MD
CONTACT
Shrasti Lohiya
CONTACT
The University of Texas Health Science Center, Houston
Other
Effects of a Mobile App-Based Mindfulness Intervention in Persons with Spinal Cord Injury and Chronic Pain: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07705906
Brain Diseases, Cardiovascular Diseases
Dhaka, Dhaka Division, Bangladesh
View Trial DetailsNCT07099625
Central Nervous System Diseases, Cerebrovascular Accident With Associated Sequelae
Minneapolis, Minnesota, United States
View Trial DetailsNCT07222046
Central Nervous System Diseases, Nervous System Diseases
Sacramento, California, United States
View Trial DetailsNCT07704268
Central Nervous System Diseases, Nervous System Diseases
Shenyang, China
View Trial Details